B-cell commitment: Deciding on the players

Current Opinion in Immunology

Volumn 15, Issue 2, 2003, Pages 158-165

  Hardy, Richard R ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD24 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; CYTOKINE RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 7 RECEPTOR; LEUKOSIALIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; B LYMPHOCYTE; BIOASSAY; BONE MARROW; CELL LINEAGE; CELL MATURATION; COMPARATIVE STUDY; CYTOMETRY; FETUS LIVER; GENETIC ANALYSIS; HUMAN; KNOCKOUT MOUSE; NONHUMAN; PLAY; REVIEW; STEM CELL; TRANSGENIC ANIMAL;

EID: 0037375567     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(03)00012-8     Document Type: Review

References (54)

1. Kondo M., Weissman I.L., Akashi K. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell. 91:1997;661-672.
2. Li Y.S., Wasserman R., Hayakawa K., Hardy R.R. Identification of the earliest B lineage stage in mouse bone marrow. Immunity. 5:1996;527-535.
3. Jordan C.T., McKearn J.P., Lemischka I.R. Cellular and developmental properties of fetal hematopoietic stem cells. Cell. 61:1990;953-963.
4. McKearn J.P., Baum C., Davie J.M. Cell surface antigens expressed by subsets of pre-B cells and B cells. J. Immunol. 132:1984;332-339.
5. Petrenko O., Beavis A., Klaine M., Kittappa R., Godin I., Lemischka I.R. The molecular characterization of the fetal stem cell marker AA4. Immunity. 10:1999;691-700.
6. Allman D., Li J., Hardy R.R. Commitment to the B lymphoid lineage occurs before DH-JH recombination. J. Exp. Med. 189:1999;735-740.
7. Tudor K.S., Payne K.J., Yamashita Y., Kincade P.W. Functional assessment of precursors from murine bone marrow suggests a sequence of early B lineage differentiation events. Immunity. 12:2000;335-345.
8. Landau N.R., Schatz D.G., Rosa M., Baltimore D. Increased frequency of N-region insertion in a murine pre-B-cell line infected with a terminal deoxynucleotidyl transferase retroviral expression vector. Mol. Cell Biol. 7:1987;3237-3243.
9. - cells as 'pro-B cells', this fraction generates both B and T cells, suggesting that TdT expression is initiated very early in lymphoid differentiation, at the CLP stage.
10. Wrammert J., Kallberg E., Agace W.W., Leanderson T. Ly6C expression differentiates plasma cells from other B cell subsets in mice. Eur. J. Immunol. 32:2002;97-103.
11. Loffert D., Schaal S., Ehlich A., Hardy R.R., Zou Y.R., Muller W., Rajewsky K. Early B-cell development in the mouse: insights from mutations introduced by gene targeting. Immunol Rev. 137:1994;135-153.
12. low cells do not, suggesting a branch point from CLP to DC or B lineage development.
13. + phenotype.
14. •].
15. Kawamoto H., Ikawa T., Ohmura K., Fujimoto S., Katsura Y. T cell progenitors emerge earlier than B cell progenitors in the murine fetal liver. Immunity. 12:2000;441-450.
16. Mebius R.E., Miyamoto T., Christensen J., Domen J., Cupedo T., Weissman I.L., Akashi K. The fetal liver counterpart of adult common lymphoid progenitors gives rise to all lymphoid lineages, CD45+CD4+CD3- cells, as well as macrophages. J. Immunol. 166:2001;6593-6601 This paper provides data to suggest that a cell fraction phenotypically similar to the bone marrow CLP is not as lineage-restricted in fetal liver.
17. Egawa T., Kawabata K., Kawamoto H., Amada K., Okamoto R., Fujii N., Kishimoto T., Katsura Y., Nagasawa T. The earliest stages of B cell development require a chemokine stromal cell-derived factor/pre-B cell growth-stimulating factor. Immunity. 15:2001;323-334 This paper reports on early hematopoietic lineage populations in SDF1 and SDF1 receptor (CXCR4) deficient mice, suggesting that this interaction is more important than the IL-7-IL-7R interaction for early developing B lineage cells in fetal liver. The failure of these mice to delineate a B/T restricted precursor in fetal liver may be consistent with earlier reports of the close association of B and myeloid lineages in fetal liver precursors, suggesting a different lineage branching in fetal development, in comparison to that in the bone marrow of adult animals.
18. -) does not occur in bone marrow of IL-7R deficient mice. This analysis reveals that the block in development in these mice occurs significantly earlier than previously thought, and shows that the CLP stage in bone marrow is dependent on IL-7-IL7R signaling.
19. Park L.S., Martin U., Garka K., Gliniak B., Di Santo J.P., Muller W., Largaespada D.A., Copeland N.G., Jenkins N.A., Farr A.G.et al. Cloning of the murine thymic stromal lymphopoietin (TSLP) receptor: formation of a functional heteromeric complex requires interleukin 7 receptor. J. Exp. Med. 192:2000;659-670.
20. Sims J.E., Williams D.E., Morrissey P.J., Garka K., Foxworthe D., Price V., Friend S.L., Farr A., Bedell M.A., Jenkins N.A.et al. Molecular cloning and biological characterization of a novel murine lymphoid growth factor. J. Exp. Med. 192:2000;671-680.
21. Pandey A., Ozaki K., Baumann H., Levin S.D., Puel A., Farr A.G., Ziegler S.F., Leonard W.J., Lodish H.F. Cloning of a receptor subunit required for signaling by thymic stromal lymphopoietin. Nat. Immunol. 1:2000;59-64.
22. Carvalho T.L., Mota-Santos T., Cumano A., Demengeot J., Vieira P. Arrested B lymphopoiesis and persistence of activated B cells in adult interleukin 7(-/-) mice. J. Exp. Med. 194:2001;1141-1150 This paper reports on the presence of B-1 and MZ B cells in the peripheral tissues of mice deficient for IL-7, even though bone marrow B cell development appears to be completely blocked.
23. Hardy R.R., Hayakawa K. A developmental switch in B lymphopoiesis. Proc. Natl. Acad. Sci. U.S.A. 88:1991;11550-11554.
24. Cumano A., Paige C.J., Iscove N.N., Brady G. Bipotential precursors of B cells and macrophages in murine fetal liver. Nature. 356:1992;612-615.
25. +) for B cell precursors in bone marrow that also generate myeloid lineage cells (bi-potential precursors).
26. Hao Z., Rajewsky K. Homeostasis of peripheral B cells in the absence of B cell influx from the bone marrow. J. Exp. Med. 194:2001;1151-1164 The authors show that blocking Ig rearrangement after birth using a regulated Rag-2 deletion system results in the production of B-1 and MZ B cells.
27. Kondo M., Scherer D.C., Miyamoto T., King A.G., Akashi K., Sugamura K., Weissman I.L. Cell-fate conversion of lymphoid-committed progenitors by instructive actions of cytokines. Nature. 407:2000;383-386.
28. Chiang M.Y., Monroe J.G. Role for transcription Pax5A factor in maintaining commitment to the B cell lineage by selective inhibition of granulocyte-macrophage colony-stimulating factor receptor expression. J. Immunol. 166:2001;6091-6098 The authors present evidence of a mechanism for Pax5 suppression of non-B lineage cell fates.
29. Sitnicka E., Bryder D., Theilgaard-Monch K., Buza-Vidas N., Adolfsson J., Jacobsen S.E. Key role of flt3 ligand in regulation of the common lymphoid progenitor but not in maintenance of the hematopoietic stem cell pool. Immunity. 17:2002;463 The authors describe the requirement for Flt3 signaling for development of CLP-stage cells. Although the CLP stage is at least 10-fold decreased in Flt3-null mice, normal levels of hematopoietic stem cell and common myeloid progenitor compartments are detected, both by cell surface phenotype and functional activity, indicating that Flt3 plays a key role only in development along the lymphoid pathway.
30. Scott E.W., Simon M.C., Anastasi J., Singh H. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science. 265:1994;1573-1577.
31. McKercher S.R., Torbett B.E., Anderson K.L., Henkel G.W., Vestal D.J., Baribault H., Klemsz M., Feeney A.J., Wu G.E., Paige C.J.et al. Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J. 15:1996;5647-5658.
32. DeKoter R.P., Singh H. Regulation of B lymphocyte and macrophage development by graded expression of PU.1. Science. 288:2000;1439-1441.
33. DeKoter R.P., Lee H.J., Singh H. PU.1 regulates expression of the interleukin-7 receptor in lymphoid progenitors. Immunity. 16:2002;297-309 The authors present evidence that the block in B-cell development in PU.1 null mice can be overcome by expression of the IL-7Rα chain, which is normally induced by PU.1 expression.
34. Anderson M.K., Weiss A.H., Hernandez-Hoyos G., Dionne C.J., Rothenberg E.V. Constitutive expression of PU.1 in fetal hematopoietic progenitors blocks T cell development at the pro-T cell stage. Immunity. 16:2002;285-296.
35. Lin H., Grosschedl R. Failure of B-cell differentiation in mice lacking the transcription factor EBF. Nature. 376:1995;263-267.
36. Bain G., Robanus Maandag E.C., te Riele H.P., Feeney A.J., Sheehy A., Schlissel M., Shinton S.A., Hardy R.R., Murre C. Both E12 and E47 allow commitment to the B cell lineage. Immunity. 6:1997;145-154.
37. Romanow W.J., Langerak A.W., Goebel P., Wolvers-Tettero I.L., van Dongen J.J., Feeney A.J., Murre C. E2A and EBF act in synergy with the V(D)J recombinase to generate a diverse immunoglobulin repertoire in nonlymphoid cells. Mol. Cell. 5:2000;343-353.
38. Goebel P., Janney N., Valenzuela J.R., Romanow W.J., Murre C., Feeney A.J. Localized gene-specific induction of accessibility to V(D)J recombination induced by E2A and early B cell factor in nonlymphoid cells. J. Exp. Med. 194:2001;645-656 The authors describe experiments designed to establish the role of E2A and EBF in early B-lineage development. They report that the simultaneous expression of these transcription factors allows heavy chain rearrangement in non-lymphoid cells, indicating that both chromatin remodeling and the induction of key recombinase components is mediated by E2A and EBF.
39. O'Riordan M., Grosschedl R. Coordinate regulation of B cell differentiation by the transcription factors EBF and E2A. Immunity. 11:1999;21-31.
40. Nutt S.L., Heavey B., Rolink A.G., Busslinger M. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature. 401:1999;556-562.
41. Rolink A.G., Nutt S.L., Melchers F., Busslinger M. Long-term in vivo reconstitution of T-cell development by Pax5-deficient B-cell progenitors. Nature. 401:1999;603-606.
42. Mikkola I., Heavey B., Horcher M., Busslinger M. Reversion of B cell commitment upon loss of Pax5 expression. Science. 297:2002;110-113 The authors demonstrate the continuing requirement for Pax5 expression through the pro-B stage, not just at the initial commitment stage, as demonstrated by a regulated Pax5 deletion system.
43. Kee B.L., Rivera R.R., Murre C. Id3 inhibits B lymphocyte progenitor growth and survival in response to TGF-beta. Nat. Immunol. 2:2001;242-247 The authors define the molecular pathway for B cell precursor growth inhibition by TGF-β. The authors report that TGF-β growth inhibition is mediated by the upregulation of Id3, which in turn acts to inhibit the function of E proteins in promoting survival of early B-lineage cells, thereby establishing a new role for E proteins.
44. Lee G., Namen A.E., Gillis S., Ellingsworth L.R., Kincade P.W. Normal B cell precursors responsive to recombinant murine IL-7 and inhibition of IL-7 activity by transforming growth factor-beta. J. Immunol. 142:1989;3875-3883.
45. Robey E., Chang D., Itano A., Cado D., Alexander H., Lans D., Weinmaster G., Salmon P. An activated form of Notch influences the choice between CD4 and CD8 T cell lineages. Cell. 87:1996;483-492.
46. Washburn T., Schweighoffer E., Gridley T., Chang D., Fowlkes B.J., Cado D., Robey E. Notch activity influences the alphabeta versus γδ T cell lineage decision. Cell. 88:1997;833-843.
47. Anderson A.C., Robey E.A., Huang Y.H. Notch signaling in lymphocyte development. Curr. Opin. Genet. Dev. 11:2001;554-560.
48. Pui J.C., Allman D., Xu L., DeRocco S., Karnell F.G., Bakkour S., Lee J.Y., Kadesch T., Hardy R.R., Aster J.C.et al. Notch1 expression in early lymphopoiesis influences B versus T lineage determination. Immunity. 11:1999;299-308.
49. Wilson A., MacDonald H.R., Radtke F. Notch 1-deficient common lymphoid precursors adopt a B cell fate in the thymus. J. Exp. Med. 194:2001;1003-1012 The authors demonstrate the crucial function of Notch-1 in signaling the T-cell fate, by analyzing the development of Notch-1 deficient precursors in the thymus. Such cells rather than developing along the T lineage, instead generate B cells in the thymus.
50. Koch U., Lacombe T.A., Holland D., Bowman J.L., Cohen B.L., Egan S.E., Guidos C.J. Subversion of the T/B lineage decision in the thymus by lunatic fringe-mediated inhibition of Notch-1. Immunity. 15:2001;225-236 This is a further indication of the critical role of Notch-1 signaling in T-cell development. Inhibition of Notch-1 signaling by ectopic expression of lunatic fringe results in the re-direction of T-cell development along the B lineage in thymus.
51. Izon D.J., Aster J.C., He Y., Weng A., Karnell F.G., Patriub V., Xu L., Bakkour S., Rodriguez C., Allman D.et al. Deltex1 redirects lymphoid progenitors to the B cell lineage by antagonizing Notch1. Immunity. 16:2002;231-243 The authors relay the unexpected finding that Deltex1, thought to be a positive modulator of Notch-1 function, instead acts to re-direct T-cell development in thymus along the B lineage, both in vivo and in vitro. Their data suggest that a balance between inductive and inhibitory signals converging on the Notch pathway serves to regulate the T/B lineage choice.
52. van de Wetering M., de Lau W., Clevers H. WNT signaling and lymphocyte development. Cell. 109(Suppl):2002;S13-S19.
53. Reya T., O'Riordan M., Okamura R., Devaney E., Willert K., Nusse R., Grosschedl R. Wnt signaling regulates B lymphocyte proliferation through a LEF-1 dependent mechanism. Immunity. 13:2000;15-24.
54. Yamane T., Kunisada T., Tsukamoto H., Yamazaki H., Niwa H., Takada S., Hayashi S.I. Wnt signaling regulates hemopoiesis through stromal cells. J. Immunol. 167:2001;765-772 This paper shows that WNT signaling can affect hematopoiesis indirectly, by acting on stromal cells to inhibit B-cell development in vitro. In contrast, cultures of early B-lineage cells without stromal cells were unaffected by the addition of Wnt-3a conditioned medium.